Skip to main content

Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines

  • Protocol
  • First Online:
Book cover Neisseria meningitidis

Abstract

Vaccination has reduced morbidity and mortality of many diseases that previously caused devastating epidemics and deaths globally. Vaccines as a biological product may contain microorganisms or their derivatives. This aspect together with the fact that they are administered to healthy individuals (mainly children) means that approximately 70% of vaccines development time is dedicated to quality control. Monoclonal antibodies (MAbs) have become essential analytical tools for application in ELISAs, Western and Dot blotting, immunoprecipitation, and flow cytometric assays that ensure the quality control of vaccines. The aim of this work is to present a review of the methods used to obtain a platform of MAbs against Neisseria meningitidis polysaccharide antigens to use as an analytical tool for quality control of anti-meningococcal polysaccharide (Ps) vaccines. The MAbs obtained are used in five sandwich ELISAs developed for Ps quantification. The assays showed good reproducibility and repeatability, with quantitation and detection limits below 1 ng/mL. Dot Blot, as the Identity test of the Ps vaccine, was carried out to positively identify licensed and experimental vaccines. All assays described are suitable for the screening of multiple vaccine samples and could be useful for monitoring lot-to-lot consistency and stability.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Greenwood B (2014) The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond Ser B Biol Sci 369(1645):20130433

    Article  Google Scholar 

  2. Bustreo F, Okwo-Bele JM, Kamara L (2015) World Health Organization perspectives on the contribution of the global alliance for vaccines and immunization on reducing child mortality. Arch Dis Child 100(Suppl 1):s34–s37

    Article  Google Scholar 

  3. WHO. Web page: http://www.who.int/immunization/documents/positionpapers/en/. Immunization, vaccines and biologicals

  4. US Pharmacopeia (2007) Guideline for Submitting Requests for Revision to USP-NF. V3.1 April.VACCINES

    Google Scholar 

  5. WHO. Web page http://www.who.int/immunization/quality_safety/en/. Vaccine and immunization quality and safety

  6. CECMED (2000) Requisitos para la liberación de lotes de vacunas. Regulación No.19-2000. CECMED, La Habana

    Google Scholar 

  7. European Pharmacopoeia 5.0. 01/2005:20701. 2.7.1. Immunochemical methods. p 1879

    Google Scholar 

  8. Ochoa RF (2013) Técnicas inmunoenzimáticas en el desarrollo clínico de vacunas, Primera Edición. Finlay Ediciones, Havana, Cuba

    Google Scholar 

  9. Saydam M, Rigsby P, Mawas F (2014) A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae B Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations. Biologicals 42:29–33

    Article  CAS  Google Scholar 

  10. Saleem M, Kamal M (2008) Monoclonal antibodies in clinical diagnosis: a brief review application. Afr J Biotechnol 7:923–925

    CAS  Google Scholar 

  11. Payne WJ, Marshall DL, Shockley RK, Martin WJ (1988) Clinical laboratory applications of monoclonal antibodies. Clin Microbiol Rev 1:313–329

    Article  Google Scholar 

  12. Falero G, Rodríguez BL, Rodríguez I, Campos J, Ledon T, Valle E, Silva Y, Marrero K, Suzarte E, Valmaseda T, Moreno A, Fando R (2003) Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae. Hybrid Hybridomics 22(5):315–320

    Article  CAS  Google Scholar 

  13. Barberá R, Domínguez F, Otero O, Gutiérrez M, Falero G, Reyes G, Sotolongo F, Sierra G (2011) Development and characterization of murine monoclonal antibody specific for the P1.4 PorA proteins from strain B: 4:P1.(7b).4. of Neisseria meningitidis. Vaccimonitor 20:6–10

    Google Scholar 

  14. Waliza A, Shyamasree G (2013) Monoclonal antibodies: a tool in clinical research. Indian J Clin Med 4:9–21

    Article  Google Scholar 

  15. Hnasko RM, Stanker LH (2015) Hybridoma technology. In: ELISA: methods and protocols, Methods in molecular biology, vol 1318. Springer Science+Business Media, New York

    Chapter  Google Scholar 

  16. Ward PA et al (1999) Monoclonal antibody production. A report of the committee on methods of producing monoclonal antibodies. Institute for laboratory animal research. National Research Council

    Google Scholar 

  17. Reyes F, Amin N, Otero O, Aguilar A, Cuello M, Valdés Y, García LG, Cardoso D, Camacho F (2013) Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests. Biologicals 41(4):275–278

    Article  CAS  Google Scholar 

  18. Yokoyama WM (2001) Monoclonal antibody supernatant and ascites fluid production. Curr Protoc Immunol 40:2.6.1–2.6.9

    Google Scholar 

  19. Fitzgerald J, Leonard P, Darcy E, O’Kennedy R (2011) Immunoaffinity chromatography. Methods Mol Biol 681:35–59

    Article  CAS  Google Scholar 

  20. ImmunoReagents Inc. (2015) Antibody purification methods. IRU - ImmunoReagents University, Raleigh, NC

    Google Scholar 

  21. Ezzatifar F, Majidi J, Baradaran B, Maleki LA, Abdolalizadeh J, Yousefi M (2015) Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of Balb/c mice. Adv Pharm Bull 5(1):97–102

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Amersham Pharmacia Biotech (2001) Affinity chromatography. Principles and methods. Handbooks. Editon AC 18-1022-29. Amersham Pharmacia Biotech, Little Chalfont

    Google Scholar 

  23. Beatty JD, Beatty BG, Vlahos WG (1987) Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 100:173–179

    Article  CAS  Google Scholar 

  24. Johnson M (2013) Mouse antibody isotypes/classes and subclasses. Mater methods 3:152 (Labome. http://www.labome.com/method/Mouse-Antibody.html)

  25. Clark M Antibody-antigen reactions. Department of pathology. University of Cambridge, Cambridge

    Google Scholar 

  26. Frank SA (2002) Specificity and cross-reactivity. In: Immunology and evolution of infectious disease. Princeton University Press, Princeton, NJ

    Google Scholar 

  27. Agnememel A, Traincard F, Dartevelle S, Mulard L, Mahamane AE, Oukem-Boyer OO, Denizon M, Kacou-N Douba A, Dosso M, Gake B, Lombart JP, Taha MK (2015) Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X. Clin Microbiol 53:449–454

    Article  CAS  Google Scholar 

  28. Wedege E, Høiby EA, Rosenqvist E, Frøholm LO (1990) Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 31:195–201

    Article  CAS  Google Scholar 

  29. Ortika BD, Habib M, Dunne EM, Porter BD, Satzke C (2013) Production of latex agglutination reagents for pneumococcal serotyping. BMC Res Notes 6:49

    Article  Google Scholar 

  30. Cook MC, Gibeault S, Filippenko V, Ye Q, Wang J, Kunkel JP (2013) Serogroup quantitation of multivalent polysaccharide and polysaccharide conjugate meningococcal vaccines from China. Biologicals 41:261–268

    Article  CAS  Google Scholar 

  31. Cook MC, Bliu A, Kunkel JP (2013) Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods. Vaccine 31:3702–3711

    Article  CAS  Google Scholar 

  32. Reyes F, Otero O, Cuello M, Amin N, García L, Cardoso D, Camacho F (2014) Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines. J Immunol Methods 407:58–62

    Article  CAS  Google Scholar 

  33. Chen PS, Toribara TY, Warner H (1956) Microdetermination of phosphorus. Anal Chem 28:1756–1758

    Article  CAS  Google Scholar 

  34. Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604–611

    Article  CAS  Google Scholar 

  35. Lamb DH, Lei QP, Hakim N, Rizzo S, Cash P (2005) Determination of meningococcal polysaccharides by capillary zone electrophoresis. Anal Biochem 338:263–269

    Article  CAS  Google Scholar 

  36. Kao G, Tsai CM (2004) Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD). Vaccine 22:335–344

    Article  CAS  Google Scholar 

  37. Crowther JR (2009) The ELISA guidebook, Methods in molecular biology, vol 516. Humana Press, New York

    Google Scholar 

  38. Plikaytis BD, Carlone GM, Edmonds P, Mayer LW (1986) Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base-pair number after gel electrophoresis. Anal Biochem 152:346–364

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Reinaldo Acevedo .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

González, E. et al. (2019). Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines. In: Seib, K., Peak, I. (eds) Neisseria meningitidis. Methods in Molecular Biology, vol 1969. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9202-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9202-7_13

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-4939-9201-0

  • Online ISBN: 978-1-4939-9202-7

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics